Oncogenesis driven by the Ras/Raf pathway requires the SUMO E2 ligase Ubc9

Overview of attention for article published in Proceedings of the National Academy of Sciences of the United States of America, March 2015

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 6 X posts from 5 X users, with an upper bound of 20,603 followers.

RT @rnomics: SUMO pathway supports KRAS-driven oncogenesis [Cell Biology]: The small GTPase KRAS is frequently mutated in… http://t.co/gJiL…

Oncogenesis driven by the Ras/Raf pathway requires the SUMO E2 ligase Ubc9. http://t.co/R6EG8y5Vph

Another KRAS synthetic lethal / non-oncogene addiction (SUMO E2 ligase Ubc9) http://t.co/MbzYmxs3oq

Oncogenesis Driven by the Ras/Raf Pathway Requires the SUMO E2 Ligase Ubc9 @PNASNews http://t.co/RfW6tkhqCx

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.